These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30972688)

  • 1. Metabolic stroke in a patient with bi-allelic OPA1 mutations.
    Zerem A; Yosovich K; Rappaport YC; Libzon S; Blumkin L; Ben-Sira L; Lev D; Lerman-Sagie T
    Metab Brain Dis; 2019 Aug; 34(4):1043-1048. PubMed ID: 30972688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations.
    Nasca A; Rizza T; Doimo M; Legati A; Ciolfi A; Diodato D; Calderan C; Carrara G; Lamantea E; Aiello C; Di Nottia M; Niceta M; Lamperti C; Ardissone A; Bianchi-Marzoli S; Iarossi G; Bertini E; Moroni I; Tartaglia M; Salviati L; Carrozzo R; Ghezzi D
    Orphanet J Rare Dis; 2017 May; 12(1):89. PubMed ID: 28494813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.
    Lee J; Jung SC; Hong YB; Yoo JH; Koo H; Lee JH; Hong HD; Kim SB; Chung KW; Choi BO
    Mol Med Rep; 2016 Jul; 14(1):33-40. PubMed ID: 27150940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family.
    Ahmad KE; Davis RL; Sue CM
    J Neurol; 2015 Oct; 262(10):2323-8. PubMed ID: 26194196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.
    Ham M; Han J; Osann K; Smith M; Kimonis V
    Mitochondrion; 2019 May; 46():262-269. PubMed ID: 30165240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy.
    Baris O; Delettre C; Amati-Bonneau P; Surget MO; Charlin JF; Catier A; Derieux L; Guyomard JL; Dollfus H; Jonveaux P; Ayuso C; Maumenee I; Lorenz B; Mohammed S; Tourmen Y; Bonneau D; Malthièry Y; Hamel C; Reynier P
    Hum Mutat; 2003 Jun; 21(6):656. PubMed ID: 14961560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier.
    Bonifert T; Karle KN; Tonagel F; Batra M; Wilhelm C; Theurer Y; Schoenfeld C; Kluba T; Kamenisch Y; Carelli V; Wolf J; Gonzalez MA; Speziani F; Schüle R; Züchner S; Schöls L; Wissinger B; Synofzik M
    Brain; 2014 Aug; 137(Pt 8):2164-77. PubMed ID: 24970096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Description of Inheritance of a Postzygotic
    Alter S; Farassat N; Küchlin S; Lagrèze WA; Fischer J
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural model of the OPA1 GTPase domain may explain the molecular consequences of a novel mutation in a family with autosomal dominant optic atrophy.
    Dadgar S; Hagens O; Dadgar SR; Haghighi EN; Schimpf S; Wissinger B; Garshasbi M
    Exp Eye Res; 2006 Sep; 83(3):702-6. PubMed ID: 16698014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
    Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Impairment Mechanisms of Novel OPA1 Mutations Predicted by Molecular Modeling in Patients With Autosomal Dominant Optic Atrophy and Auditory Neuropathy Spectrum Disorder.
    Namba K; Mutai H; Takiguchi Y; Yagi H; Okuyama T; Oba S; Yamagishi R; Kaneko H; Shintani T; Kaga K; Matsunaga T
    Otol Neurotol; 2016 Apr; 37(4):394-402. PubMed ID: 26905822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.
    Formichi P; Radi E; Giorgi E; Gallus GN; Brunetti J; Battisti C; Rufa A; Dotti MT; Franceschini R; Bracci L; Federico A
    J Neurol Sci; 2015 Apr; 351(1-2):99-108. PubMed ID: 25796301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant optic atrophy with
    Maeda-Katahira A; Nakamura N; Hayashi T; Katagiri S; Shimizu S; Ohde H; Matsunaga T; Kaga K; Nakano T; Kameya S; Matsuura T; Fujinami K; Iwata T; Tsunoda K
    Mol Vis; 2019; 25():559-573. PubMed ID: 31673222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-system neurological disease is common in patients with OPA1 mutations.
    Yu-Wai-Man P; Griffiths PG; Gorman GS; Lourenco CM; Wright AF; Auer-Grumbach M; Toscano A; Musumeci O; Valentino ML; Caporali L; Lamperti C; Tallaksen CM; Duffey P; Miller J; Whittaker RG; Baker MR; Jackson MJ; Clarke MP; Dhillon B; Czermin B; Stewart JD; Hudson G; Reynier P; Bonneau D; Marques W; Lenaers G; McFarland R; Taylor RW; Turnbull DM; Votruba M; Zeviani M; Carelli V; Bindoff LA; Horvath R; Amati-Bonneau P; Chinnery PF
    Brain; 2010 Mar; 133(Pt 3):771-86. PubMed ID: 20157015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations.
    Cohn AC; Toomes C; Potter C; Towns KV; Hewitt AW; Inglehearn CF; Craig JE; Mackey DA
    Am J Ophthalmol; 2007 Apr; 143(4):656-62. PubMed ID: 17306754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.
    Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS
    Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPA1-related disorders: Diversity of clinical expression, modes of inheritance and pathophysiology.
    Chao de la Barca JM; Prunier-Mirebeau D; Amati-Bonneau P; Ferré M; Sarzi E; Bris C; Leruez S; Chevrollier A; Desquiret-Dumas V; Gueguen N; Verny C; Hamel C; Miléa D; Procaccio V; Bonneau D; Lenaers G; Reynier P
    Neurobiol Dis; 2016 Jun; 90():20-6. PubMed ID: 26311407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset Behr syndrome due to compound heterozygous mutations in OPA1.
    Bonneau D; Colin E; Oca F; Ferré M; Chevrollier A; Guéguen N; Desquiret-Dumas V; N'Guyen S; Barth M; Zanlonghi X; Rio M; Desguerre I; Barnerias C; Momtchilova M; Rodriguez D; Slama A; Lenaers G; Procaccio V; Amati-Bonneau P; Reynier P
    Brain; 2014 Oct; 137(Pt 10):e301. PubMed ID: 25012220
    [No Abstract]   [Full Text] [Related]  

  • 19. Biallelic Optic Atrophy 1 (
    Othman BA; Ong JE; Dumitrescu AV
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two novel intronic OPA1 mutations resulting in aberrant pre-mRNA splicing.
    Bolognini R; Gerth-Kahlert C; Abegg M; Bartholdi D; Mathis N; Sturm V; Gallati S; Schaller A
    BMC Med Genet; 2017 Feb; 18(1):22. PubMed ID: 28245802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.